ENDONOVO THERAPEUTICS, INC. Business Combination, Contingent Consideration, Liability, Noncurrent
ENDONOVO THERAPEUTICS, INC. (ENDV) had Business Combination, Contingent Consideration, Liability, Noncurrent of $79.83 thousand as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2023-12-29
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $79.83K.
- 2023-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $79.83K.
- 2023-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $79.83K.
- 2022-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $79.83K.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2023-09-30 | $79.83K 10-Q · filed 2023-12-29 |
| 2023-06-30 | $79.83K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $79.83K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $79.83K 10-Q · filed 2023-12-29 |
| 2022-09-30 | $79.83K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $79.83K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $79.83K 10-Q · filed 2022-05-19 |
| 2021-12-31 | $79.83K 10-Q · filed 2022-11-21 |
| 2020-12-31 | $155.00K 10-K · filed 2022-04-14 |